VEGFA and B-cell chronic lymphocytic leukemia: High serum or plasma concentrations of VEGF were reportedly higher in CLL patients than in healthy controls and defined a subset of CLL patients with a poor clinical outcome [64,65,74,77,80,84,109] (Table 1).